Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Cooperberg

Showing results (401-410 of 522) with videos related to

Pageof 53
Sort By:
European Urology|November 11, 2021
Hyperpolarized 1-[<sup>13</sup>C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Immune Checkpoint Inhibitor Therapy in Prostate CancerIvan de Kouchkovsky, Hsin-Yu Chen, Michael A Ohliger, et al.
BJU International|June 10, 2026
The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) studyHeather H Cheng, Kara N Maxwell, Keyan Salari, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 19, 2026
Marital status and post-radical prostatectomy outcomes: results from the SEARCH databaseAlanna Burwell, Jaruda Ithisuphalap, Jessica L Janes, et al.
Prostate Cancer and Prostatic Diseases|April 11, 2024
Addressing racial disparities in prostate cancer pathology prediction models: external validation and comparison of four models of pathological outcome prediction before radical prostatectomy in the multiethnic SEARCH cohortMahdi Mottaghi, Lin Gu, Sriram Deivasigamani, et al.
Prostate Cancer and Prostatic Diseases|September 1, 2022
Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)?Zachary Klaassen, Lauren Howard, Christopher J D Wallis, et al.
Cancer Causes & Control : CCC|July 5, 2023
Are associations between obesity and prostate cancer outcomes following radical prostatectomy the same in smokers and non-smokers? Results from the SEARCH CohortIvy T Liu, Lin Gu, Amanda M De Hoedt, et al.
European Urology|November 5, 2020
Multiple Tissue Biomarkers Independently and Additively Predict Prostate Cancer Pathology OutcomesMatthew R Cooperberg, Janet E Cowan, Karla J Lindquist, et al.
European Urology|July 19, 2017
A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate CancerDaniel E Spratt, Robert T Dess, Zachary S Zumsteg, et al.
Urology Practice|October 25, 2024
Feasibility of Pay for Performance and Transparency Interventions on the Selection and Quality of Observational Management for Patients With Low-Risk Prostate Cancer in the Community PracticeFranklin D Gaylis, Michael S Leapman, Shellie D Ellis, et al.
Cancer Medicine|November 13, 2019
Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patientsJeffrey Belkora, June M Chan, Matthew R Cooperberg, et al.
Pageof 53

Showing results (401-410 of 522) with videos related to

Sort By:
Pageof 53
European Urology|November 11, 2021
Hyperpolarized 1-[<sup>13</sup>C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Immune Checkpoint Inhibitor Therapy in Prostate CancerIvan de Kouchkovsky, Hsin-Yu Chen, Michael A Ohliger, et al.
BJU International|June 10, 2026
The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) studyHeather H Cheng, Kara N Maxwell, Keyan Salari, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 19, 2026
Marital status and post-radical prostatectomy outcomes: results from the SEARCH databaseAlanna Burwell, Jaruda Ithisuphalap, Jessica L Janes, et al.
Prostate Cancer and Prostatic Diseases|April 11, 2024
Addressing racial disparities in prostate cancer pathology prediction models: external validation and comparison of four models of pathological outcome prediction before radical prostatectomy in the multiethnic SEARCH cohortMahdi Mottaghi, Lin Gu, Sriram Deivasigamani, et al.
Prostate Cancer and Prostatic Diseases|September 1, 2022
Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)?Zachary Klaassen, Lauren Howard, Christopher J D Wallis, et al.
Cancer Causes & Control : CCC|July 5, 2023
Are associations between obesity and prostate cancer outcomes following radical prostatectomy the same in smokers and non-smokers? Results from the SEARCH CohortIvy T Liu, Lin Gu, Amanda M De Hoedt, et al.
European Urology|November 5, 2020
Multiple Tissue Biomarkers Independently and Additively Predict Prostate Cancer Pathology OutcomesMatthew R Cooperberg, Janet E Cowan, Karla J Lindquist, et al.
European Urology|July 19, 2017
A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate CancerDaniel E Spratt, Robert T Dess, Zachary S Zumsteg, et al.
Urology Practice|October 25, 2024
Feasibility of Pay for Performance and Transparency Interventions on the Selection and Quality of Observational Management for Patients With Low-Risk Prostate Cancer in the Community PracticeFranklin D Gaylis, Michael S Leapman, Shellie D Ellis, et al.
Cancer Medicine|November 13, 2019
Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patientsJeffrey Belkora, June M Chan, Matthew R Cooperberg, et al.
Pageof 53